Obesity is a condition that affects nearly 42% of the population and is associated with over $170 billion in medical costs in the U.S., according to the Centers for Disease Control and Prevention
Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity
The mitochondrial membrane permeabilization results in the release of the proapoptotic factors from the mitochondrial intermembrane space, cytochrome c [194], AIF [195], and endonuclease G [196], to the cytosol
Compounded medications are made in State Board of Pharmacy-licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities
Furthermore, we also examined whether the risks differed across different drug types, treatment dosage, follow-up duration, study designs, and baseline body mass index [BMI]
